WANTAI BIOLOGICAL(SH:603392) Sou Hu Cai Jing·2025-08-03 20:03Core Viewpoint - WanTai Bio (603392) reported a closing price of 58.06 yuan on August 1, 2025, with a decrease of 0.82% and a trading volume of 34,100 shares, resulting in a transaction amount of 198 million yuan [1] Trading Information Summary - On August 1, the capital flow for WanTai Bio showed a net outflow of 10.65 million yuan from main funds, accounting for 5.37% of the total transaction amount; a net outflow of 143,600 yuan from speculative funds, accounting for 0.07%; and a net inflow of 10.79 million yuan from retail investors, accounting for 5.45% [2][5] Company Announcement Summary - WanTai Bio announced the redemption of 700 million yuan of idle raised funds for cash management, specifically for a structured deposit product from Industrial and Commercial Bank of China with a term of 365 days [3] - The company approved the use of up to 2 billion yuan and 1.5 billion yuan of temporarily idle non-public offering funds for safe and liquid principal-protected products, with a maximum single product term of 12 months [3] - As of the announcement date, the company had invested a total of 2.129 billion yuan in financial management over the past twelve months, recovering 1.55 billion yuan in principal and earning 38.19 million yuan, with 579.15 million yuan still unrecovered [3]